1. Home
  2. ITOS vs TSBK Comparison

ITOS vs TSBK Comparison

Compare ITOS & TSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITOS
  • TSBK
  • Stock Information
  • Founded
  • ITOS 2011
  • TSBK 1915
  • Country
  • ITOS United States
  • TSBK United States
  • Employees
  • ITOS N/A
  • TSBK N/A
  • Industry
  • ITOS Biotechnology: Biological Products (No Diagnostic Substances)
  • TSBK Banks
  • Sector
  • ITOS Health Care
  • TSBK Finance
  • Exchange
  • ITOS Nasdaq
  • TSBK Nasdaq
  • Market Cap
  • ITOS 270.7M
  • TSBK 248.8M
  • IPO Year
  • ITOS 2020
  • TSBK 1998
  • Fundamental
  • Price
  • ITOS $9.99
  • TSBK $30.44
  • Analyst Decision
  • ITOS Hold
  • TSBK
  • Analyst Count
  • ITOS 6
  • TSBK 0
  • Target Price
  • ITOS $10.60
  • TSBK N/A
  • AVG Volume (30 Days)
  • ITOS 1.8M
  • TSBK 10.4K
  • Earning Date
  • ITOS 08-07-2025
  • TSBK 07-22-2025
  • Dividend Yield
  • ITOS N/A
  • TSBK 3.23%
  • EPS Growth
  • ITOS N/A
  • TSBK 6.24
  • EPS
  • ITOS N/A
  • TSBK 3.25
  • Revenue
  • ITOS $35,000,000.00
  • TSBK $76,813,000.00
  • Revenue This Year
  • ITOS N/A
  • TSBK N/A
  • Revenue Next Year
  • ITOS N/A
  • TSBK N/A
  • P/E Ratio
  • ITOS N/A
  • TSBK $9.37
  • Revenue Growth
  • ITOS 177.89
  • TSBK 2.71
  • 52 Week Low
  • ITOS $4.80
  • TSBK $24.81
  • 52 Week High
  • ITOS $18.13
  • TSBK $33.98
  • Technical
  • Relative Strength Index (RSI)
  • ITOS 65.96
  • TSBK 49.02
  • Support Level
  • ITOS $9.93
  • TSBK $29.99
  • Resistance Level
  • ITOS $10.21
  • TSBK $30.61
  • Average True Range (ATR)
  • ITOS 0.18
  • TSBK 0.61
  • MACD
  • ITOS -0.11
  • TSBK -0.03
  • Stochastic Oscillator
  • ITOS 18.07
  • TSBK 60.32

About ITOS iTeos Therapeutics Inc.

ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.

About TSBK Timberland Bancorp Inc.

Timberland Bancorp Inc is a bank holding company. It has one reportable operating segment which is defined as community banking in western Washington under the operating name Timberland Bank. The bank offers a variety of services such as checking accounts, online and mobile banking, savings accounts, home loans, consumer loans, construction loans, business rewards, cash management, small business solutions, and business checking accounts among others. It also offers loans to real estate, including residential and commercial, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.

Share on Social Networks: